John Cochran - 21 Jun 2023 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role: Director
Signature: /s/ Lori Braender, as Attorney-In-Fact
Issuer symbol: AQST
Transactions as of: 21 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 23 Jun 2023, 12:24:25 UTC
Previous filing: 24 Jun 2022
Next filing: 21 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AQST	Common Stock						99,486	21 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AQST	Stock Option (Right to Purchase)	Award	$0	+25,000		$0.000000	25,000	21 Jun 2023	Common Stock	25,000	$2.02	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date.